We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA hopes to improve the review process for combination products with a pilot program that will address institutional drawbacks to developing combination products. Read More
The FDA is clarifying how it plans to evaluate real-world evidence to determine when it could be used to support regulatory decisions for medical devices. Read More